These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 33281055

  • 21. Is the use of Pentoxifylline and Tocopherol effective in the treatment of Osteoradionecrosis of the jaws or for the treatment of medicationosteonecrosis of the jaw? An overview.
    de Morais RPL, de Aguiar AWPB, da Hora Sales PH, Carvalho AAT, Vescovi P, Meleti M, Leão JC.
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(5S1):101959. PubMed ID: 38964469
    [Abstract] [Full Text] [Related]

  • 22. Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.
    Grisar K, Schol M, Schoenaers J, Dormaar T, Coropciuc R, Vander Poorten V, Politis C.
    Int J Oral Maxillofac Surg; 2016 Dec; 45(12):1592-1599. PubMed ID: 27427547
    [Abstract] [Full Text] [Related]

  • 23. Are Bacteria Just Bystanders in the Pathogenesis of Inflammatory Jaw Conditions?
    He P, Francois K, Missaghian N, Le AD, Flynn TR, Shanti RM.
    J Oral Maxillofac Surg; 2022 Jun; 80(6):1094-1102. PubMed ID: 35405094
    [Abstract] [Full Text] [Related]

  • 24. Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.
    Soutome S, Otsuru M, Hayashida S, Yanamoto S, Sasaki M, Takagi Y, Sumi M, Kojima Y, Sawada S, Iwai H, Umeda M, Saito T.
    Support Care Cancer; 2021 Nov; 29(11):6361-6368. PubMed ID: 33884506
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Both non-surgical dental treatment and extractions increase the risk of medication-related osteonecrosis of the jaw: case-control study.
    McGowan K, Ware RS, Acton C, Ivanovski S, Johnson NW.
    Clin Oral Investig; 2019 Nov; 23(11):3967-3975. PubMed ID: 30747305
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study.
    Parise GK, Costa BN, Nogueira ML, Sassi LM, Schussel JL.
    Oral Maxillofac Surg; 2023 Sep; 27(3):507-512. PubMed ID: 35739366
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B, Zajko J, Hirjak D, Vanko L, Kupcova I, Jurkemik J, Gengelova P, Mikuskova K, Halmova K, Riznic M, Czako L.
    Bratisl Lek Listy; 2017 Sep; 118(12):724-731. PubMed ID: 29322803
    [Abstract] [Full Text] [Related]

  • 30. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Minami Y, Ogura I.
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A, Sasaki M, Schmelzeisen R, Oyama Y, Mori Y, Voss PJ.
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [Abstract] [Full Text] [Related]

  • 33. Sex difference in the morbidity and pain response with stage 0 of medication-related osteonecrosis of the jaws.
    Zhang W, Gao R, Cui Y, Ding F, Zhu S, Luo S, Liu H, Li M.
    J Oral Biosci; 2023 Dec; 65(4):324-333. PubMed ID: 37543255
    [Abstract] [Full Text] [Related]

  • 34. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
    Khominsky A, Lim M.
    Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA, Liang STY, Sax AZ, Wu K, Yom SK, Huryn JM, Estilo CL.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
    Kubota H, Miyawaki D, Mukumoto N, Ishihara T, Matsumura M, Hasegawa T, Akashi M, Kiyota N, Shinomiya H, Teshima M, Nibu KI, Sasaki R.
    Radiat Oncol; 2021 Jan 05; 16(1):1. PubMed ID: 33402192
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of Medication-Related Osteonecrosis of the Jaws without Segmental Resections: A Case Series.
    Fernandes TL, Viezzer Fernandes B, Franco GCN.
    Am J Case Rep; 2024 Feb 26; 25():e942980. PubMed ID: 38404023
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.